ARENAS M D ET AL: "Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis", NEPHROLOGY DIALYSIS TRANSPLANTATION 200706 GB LNKD- DOI:10.1093/NDT/GFL840, vol. 22, no. 6, June 2007 (2007-06), pages 1639-1644, XP002680288, ISSN: 0931-0509 (B1)

CAROLINE PLATT ET AL: "Middle-term use of Cinacalcet in paediatric dialysis patients", PEDIATRIC NEPHROLOGY ; JOURNAL OF THE INTERNATIONAL PEDIATRIC NEPHROLOGY ASSOCIATION, SPRINGER, BERLIN, DE, vol. 25, no. 1, 17 October 2009 (2009-10-17), pages 143-148, XP019761083, ISSN: 1432-198X (B1)

GOODMAN WILLIAM G: "Calcimimetic agents for the treatment of secondary hyperparathyroidism", SEMINARS IN NEPHROLOGY, GRUNE AND STRATTON, NEW YORK, NY, US, vol. 24, no. 5, 1 September 2004 (2004-09-01), pages 460-463, XP009120690, ISSN: 0270-9295, DOI: 10.1016/J.SEMNEPHROL.2004.06.006 (B1)

WO-A2-2011/014707 (B1)

PADHI DESMOND ET AL: "Clinical Pharmacokinetic and Pharmacodynamic Profile of Cinacalcet Hydrochloride", CLINICAL PHARMACOKINETICS, ADIS INTERNATIONAL LTD., AUCKLAND, NZ, vol. 48, no. 5, 1 January 2009 (2009-01-01), pages 303-311, XP009161299, ISSN: 0312-5963 [retrieved on 2009-01-01] (B1)

SCHAEFER R M ET AL: "Efficacy of cinacalcet administered with the first meal after dialysis: the SENSOR Study.", CLINICAL NEPHROLOGY AUG 2008 LNKD- PUBMED:18793528, vol. 70, no. 2, August 2008 (2008-08), pages 126-134, XP9162932, ISSN: 0301-0430 (B1)

WO-A2-2008/067199 (B1)

HARRIS ROBERT Z ET AL: "Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily", AMERICAN JOURNAL OF KIDNEY DISEASES, WB SAUNDERS CO, US, vol. 44, no. 6, 1 December 2004 (2004-12-01), pages 1070-1076, XP009162927, ISSN: 1523-6838, DOI: 10.1053/J.AJKD.2004.08.029 [retrieved on 2004-11-23] (B1)